Target intelligence / Profile preview

CXXC-type zinc finger protein 5 (CXXC5) (CXXC5)

Target
CXXC5
Molecular classification
Transcription factor, Zinc finger protein, Negative regulator of Wnt signaling
01

Overview

CXXC-type zinc finger protein 5 (CXXC5) is a negative regulator of the Wnt/beta-catenin signaling pathway that functions by binding to the Dishevelled (Dvl) protein. Specifically, the C-terminal region of CXXC5 interacts with the PDZ domain of Dvl, preventing the downstream activation of Wnt signaling which is essential for stem cell differentiation and tissue regeneration (Kim et al., 2015, Nature Communications). In conditions such as androgenetic alopecia and osteoporosis, CXXC5 is often overexpressed, leading to suppressed Wnt signaling and impaired hair growth or bone formation (Lee et al., 2017, Journal of Investigative Dermatology). Therapeutic strategies focus on disrupting this protein-protein interaction (PPI) using competitive inhibitors like the PTD-DBM peptide or small molecules like KY19382. By blocking the CXXC5-Dvl interface, these agents restore Wnt/beta-catenin signaling, thereby promoting hair follicle regeneration, accelerating wound healing, and enhancing osteoblast differentiation (Kim et al., 2021, Journal of Medicinal Chemistry). This target is particularly significant in regenerative medicine as it allows for the modulation of a major signaling pathway through a specific protein interface rather than global receptor activation.

Other names
CXXC finger protein 5Retinoid-inducible nuclear proteinRGRWIDWnt-inhibiting factor 1-like
02

Mechanism of action

Inhibition of the protein-protein interaction (PPI) between the C-terminal domain of CXXC5 and the PDZ domain of Dishevelled (Dvl) to restore and activate the Wnt/beta-catenin signaling pathway.

03

Biological functions

Signal transductionWnt signaling regulationCell proliferationOsteoblast differentiationHair follicle developmentWound healing
04

Disease associations

AlopeciaOsteoporosisWound healingCancerAcute myeloid leukemia
05

Safety considerations

Potential for oncogenesis due to systemic over-activation of Wnt signalingTissue-specific toxicityOff-target effects on other PDZ-domain containing proteins
06

Interacting drugs

PTD-DBM

1 more in the full profile.

07

Biomarkers

beta-cateninPCNA (Proliferating cell nuclear antigen)ALP (Alkaline phosphatase)CXXC5 expression levels

Beyond the preview

Go deeper on CXXC-type zinc finger protein 5 (CXXC5) (CXXC5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CXXC-type zinc finger protein 5 (CXXC5) (CXXC5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call